Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
about
Valproic acid downregulates RBP4 and elicits hypervitaminosis A-teratogenesis--a kinetic analysis on retinol/retinoic acid homeostatic systemThe proteomic and genomic teratogenicity elicited by valproic acid is preventable with resveratrol and α-tocopherolHyperammonemia associated with valproic acid concentrations.Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase 1/2.Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration.Role of carnitine in diseaseL-carnitine for acute valproic acid overdose: a systematic review of published cases.Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States.Chiral toxicology: it's the same thing...only different.The use of natural health products by paediatric patients in respite care.Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.Favorable results after conservative management of 316 valproate intoxicated patients.Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective studyCarnitine in the treatment of valproic acid-induced toxicity.Encephalopathy in an infant with infantile spasms: possible role of valproate toxicity.Pharmacological management of seizures and status epilepticus in critically ill patients.Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency.Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients.Specific safety and tolerability considerations in the use of anticonvulsant medications in children.Recent insights into the pathogenesis of hepatic encephalopathy and treatments.Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup.Rhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis.Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study.L-Arginine in the treatment of valproate overdose - five clinical cases.Antiepileptic drug poisoning: Three-year experience.Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.Posterior reversible encephalopathy syndrome in a survivor of valproate-induced acute liver failure: a case report.Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.A case of valproate induced hyperammonemic encephalopathy.Acute liver impairment after sodium valproate overdose.Challenges in diagnosing a metabolic disorder: error of pyruvate metabolism or drug induced?Serum and muscle carnitine levels in epileptic children receiving sodium valproate.Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.Resveratrol and vitamin E rescue valproic acid-induced teratogenicity: the mechanism of action.L-carnitine reduces susceptibility to bupivacaine-induced cardiotoxicity: an experimental study in rats.Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients.Valproate-induced worsening of seizures: clue to underlying diagnosis.Valproic acid-induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report.
P2860
Q28483893-34DC3E05-791A-4805-AF85-E7965BFA8489Q28542970-EEFF326D-7F06-4285-961B-06782C03D3DEQ33608984-23CA7CD4-DDDF-4A91-9B13-6F1C2A00C67EQ34069269-03921DBA-0070-4474-9DEB-53236661101FQ34248179-583AEF73-18DF-40C4-A422-28CE60077028Q34618777-42F459A8-BB03-4E7E-BB1C-2F213660B941Q34621026-9FADDAAD-24E5-494E-9FF6-0964CBB0B95EQ34785900-AFEAD116-4F34-4E3B-9324-9ED6CA3B99BFQ34979115-E800CD3B-499C-490D-AB39-C9E1FF8B8328Q35099144-89B46AA5-0F07-495D-ADBC-31D4007E417EQ35535693-F8A1A26E-9BEC-41A9-B853-ECBA17466235Q36263134-68C19E1C-8737-4E16-A233-7BDE80999C45Q36548488-1A2BC2A8-ABF8-4B2F-9E77-6901A0CF5480Q36790141-C6657C75-CCD3-4BFF-82E5-6CE326FAF0C8Q37413086-AF1176DC-B93C-4187-A464-CB43EDFF121FQ37711872-452B864C-E11D-4FC6-A4E0-1BEB14554FB7Q37867301-6522C7D2-F949-418E-8E8F-6909D97FE61EQ37963740-EB69E343-4DE0-438D-BADF-B1BD07761A0EQ37980384-624F4FED-5D41-4F9F-A5E9-DC0BA76DEBF2Q38026034-68F7E18B-7859-43E7-96E7-01F0D24B27CCQ38162913-E2AA1A81-FF9D-43A7-9D6C-10607BA32AB0Q38464083-474DCE7C-623E-4A78-8424-BDF4CDB74BFCQ38691963-C352697B-CCEC-4DCF-BAB6-2BD2A07A7C35Q38879830-22321B32-0DA2-40B4-BB52-9C3E675D8304Q38983752-FBEC2047-1767-400F-94CB-A59CB857CDA3Q41680822-A4657CBB-A82D-48B7-8009-A7ECD146D345Q42028325-A64B372C-8E30-4669-8EDD-A15E4347B7D4Q42091278-F673BAAC-80EA-4102-BE65-76A53D708B0DQ42128344-092C6904-5C25-496A-9E6C-4949A5A196F0Q42187061-342C3B7D-4867-4C4F-998A-D4963BBFB751Q42581873-60C68162-1290-45A2-A377-797D679CC41EQ45938180-67991363-5C44-473D-A964-BFC6627575F6Q46147751-FFE5FCE5-73E7-4240-9728-75168F8A5334Q46367536-4016408E-78E2-49F6-A336-DC9178161312Q46780453-AFE8306F-80CA-4B7D-9774-7D590DE81E70Q46940049-BA07080A-7D37-4565-9F1E-9A01ECE59176Q47348030-2B62E767-0E80-40C2-9C86-79AE612ADECFQ51848860-B96E33D9-848A-41FE-A360-1D701AFAA19EQ51874886-C6B9B22B-2EC3-4323-AFB5-F1D8E9E12CDBQ53521796-A8861A4A-5BAF-4AA6-85BA-FB2B353476FD
P2860
Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Science review: carnitine in t ...... xicity - what is the evidence?
@ast
Science review: carnitine in t ...... xicity - what is the evidence?
@en
Science review: carnitine in t ...... xicity - what is the evidence?
@nl
type
label
Science review: carnitine in t ...... xicity - what is the evidence?
@ast
Science review: carnitine in t ...... xicity - what is the evidence?
@en
Science review: carnitine in t ...... xicity - what is the evidence?
@nl
prefLabel
Science review: carnitine in t ...... xicity - what is the evidence?
@ast
Science review: carnitine in t ...... xicity - what is the evidence?
@en
Science review: carnitine in t ...... xicity - what is the evidence?
@nl
P2093
P2860
P921
P356
P1433
P1476
Science review: carnitine in t ...... xicity - what is the evidence?
@en
P2093
Andrea Penaloza
Mireille Gris
Philippe E R Lheureux
Soheil Zahir
P2860
P2888
P304
P356
10.1186/CC3742
P407
P577
2005-06-10T00:00:00Z
2005-10-05T00:00:00Z
P5875
P6179
1020643649